Tenaya Therapeutics (TNYA) Current Leases (2021 - 2026)

Tenaya Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• In Q1 2026, Current Leases rose 11.49% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 11.49% YoY), while the FY2025 annual figure was $3.0 million, up 8.71% from the prior year.
• Current Leases was $3.1 million for Q1 2026 at Tenaya Therapeutics, up from $3.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $4.3 million in Q4 2023 to a low of $2.1 million in Q1 2022.
• Historically, Current Leases has averaged $3.3 million across 5 years, with a median of $3.2 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Current Leases jumped 138.0% in 2022, then slumped 35.68% in 2024.
• A 5-year view of Current Leases shows it stood at $4.0 million in 2022, then grew by 7.81% to $4.3 million in 2023, then slumped by 35.68% to $2.8 million in 2024, then climbed by 8.71% to $3.0 million in 2025, then climbed by 3.15% to $3.1 million in 2026.
• The last three Current Leases figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.